巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Revance Therapeutics

    RVNC
    22.100
    0.360
    1.60%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Revance Therapeutics - 延遲價格・最後更新於 15/08 9:30
    最高位
    22.770
    最低位
    21.900
    開市價
    --
    前收市價
    22.460
    成交量(千)
    27.69
    成交額(百萬)
    5.78
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    1,615.64
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    30.000 - 11.270
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Revance Therapeutics
    證券代碼
    RVNC.US
    所屬板塊
    Biotechnology
    公司業務
    Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are Product and the Service Segment. The Products segment generates maximum revenue which is engaged in the research and development of aesthetic and therapeutic products.
    發行量
    71453287
    公司總部
    1222 Demonbreun Street, Suite 2000
    公司網址
    https://www.revance.com
    公司電郵
    jherbert@revance.com
    公司電話
    +1 615 724-7755
    暫無內容

    關於

    Revance Therapeutics(RVNC.US)所屬的行業板塊為Biotechnology。
    Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are Product and the Service Segment. The Products segment generates maximum revenue which is engaged in the research and development of aesthetic and therapeutic products.
    詳細公司背景可參考: https://www.revance.com